Is Rifamycin approved by the US FDA?

Drugs@FDA lists 1 application product line for Rifamycin, including AEMCOLO (Discontinued).

Is Rifamycin authorised in the United Kingdom?

The MHRA category lists of UK marketing authorisations include 1 product containing Rifamycin, including TRAVYC 200 MG MODIFIED-RELEASE TABLETS.

Active substance

Rifamycin

US FDA 1
UK MHRA 1

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
AEMCOLO	EQ 194MG BASE	tablet, delayed release · oral	COSMO TECHNOLOGIES	Discontinued	16 Nov 2018

UK MHRA United Kingdom — marketing authorisations

Product	Authorisation	Holder	Legal status
TRAVYC 200 MG MODIFIED-RELEASE TABLETS	PL 53269/0001	ADALVO COMPETENCE CENTER S.R.L.	POM

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.